PATENT CLAIM ANALYSIS

Application Number: 16109674
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["424", "489000"]

Abstract:
The present invention discloses a method for diagnosing and detecting cancer by bioimaging using methylene blue nanoparticle as a contrasting agent. The methylene blue nanoparticle of the present invention for use as a topical cancer targeting phototherapeutic agent is composed of only a material of which the composition is clinically used or derived from human bodies, and thus a nanopreparation in which a barrier to clinical entry is low and the possibility of commercialization is very high, exhibits near-infrared fluorescence along with cancer targeting property, a capacity of generating a singlet oxygen and the like. Therefore, the methylene blue nanoparticle in the present invention is able to detect cancerous cells by emitting visible light in irradiation conditions.

Claim (Index 16):
The method of  claim 12 , wherein each of the methylene blue nanoparticles consists of a methylene blue-fatty acid complex and an amphiphilic copolymer.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 96.0
- Lexical Diversity: 1.67568
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16109670', '14667935', '13140855', '14396533', '13566444']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7236675500963836
- 35 USC 102 Novelty (BERT): 0.6213180788466725
- Combined Prediction Score: 0.7134326029714125
- Mean Citation Score: 363.34583
- Max Citation Score: 585.2217400000002
- Similarity Product: 491.8911492364098

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test